An overview of the actions of cyclosporine and FK506

Transplantation Reviews

Volumn 17, Issue 4, 2003, Pages 165-171

  Hamawy, Majed M ^a,b   Knechtle, Stuart J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CALCINEURIN; CALCIUM ION; CELL RECEPTOR; CYCLOSPORIN; GAMMA INTERFERON; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOTRANSPLANTATION; AUTOIMMUNE DISEASE; BINDING AFFINITY; CANCER INVASION; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; FIBROSIS; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; LIVER TOXICITY; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; NEPHROTOXICITY; NEUROTOXICITY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0344668710     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(03)00039-9     Document Type: Article

References (77)

1. Dallman MJ, Mason DW: Role of thymus-derived and thymus-independent cells in murine skin allograft rejection. Transplantation 1982, 33:221
2. Kolbeck PC, Tatum AH, Sanfilippo F: Relationships among the histologic pattern, intensity, and phenotypes of T cells infiltrating renal allografts. Transplantation 1984, 38:709
3. Bolton EM, Gracie JA, Briggs JD, et al: Cellular requirements for renal allograft rejection in the athymic nude rat. J Exp Med 1989, 169:1931
4. Qian D, Weiss A: T cell antigen receptor signal transduction. Curr Opin Cell Biol 1997, 9:205
5. Alberolaila J, Takaki S, Kemer JD, et al: Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol 1997, 15:125
6. Mustelin T, Abraham RT, Rudd CE, et al: Protein tyrosine phosphorylation in T cell signaling. Front Biosci 2002, 7:d918
7. Crabtree GR: Generic signals and specific outcomes: Signaling through Ca2+, calcineurin, and NF-AT. Cell 1999, 96:611
8. Crabtree GR: Calcium, calcineurin and the control of transcription. J Biol Chem 2002, 276:2313
9. Clipstone NA, Crabtree GR: Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann N Y Acad Sci 1993, 696:20
10. Clipstone NA, Crabtree GR: Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 1992, 357:695
11. Rao A, Luo C, Hogan PG: Transcription factors of the NFAT family-regulation and function. Annu Rev Immunol 1997, 15:707
12. Kiani A, Rao A, Aramburu J: Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000, 12:359
13. Loh C, Shaw KT, Carew J, et al: Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 1996, 271:10884
14. Luo C, Shaw KT, Raghavan A, et al: Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc Natl Acad Sci U S A 1996, 93:8907
15. Masuda ES, Liu J, Imamura R, et al: Control of NFATx1 nuclear translocation by a calcineurin-regulated inhibitory domain. Mol Cell Biol 1997, 17:2066
16. Masuda ES, Imamura R, Amasaki Y, et al: Signaling into the T-cell nucleus-NFAT regulation. Cell Signal 1998, 10:599
17. Downward J, Graves JD, Warne PH, et al: Stimulation of p21ras upon T-cell activation. Nature 1990, 346:719
18. Siegel JN, Klausner RD, Rapp UR, et al: T cell antigen receptor engagement stimulates c-raf phosphorylation and induces c-raf-associated kinase activity via a protein kinase C-dependent pathway. J Biol Chem 1990, 265:18472
19. Schaeffer HJ, Weber MJ: Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 1999, 19:2435
20. Su B, Jacinto E, Hibi M, et al: JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994, 77:727
21. O'Keefe SJ, Tamura J, Kincaid RL, et al: FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992, 357:692
22. Fruman DA, Klee CB, Bierer BE, et al: Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A 1992, 89:3686
23. Borel JF, Feurer C, Gubler HU, et al: Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 1976, 6:468
24. Kino T, Hatanaka H, Hashimoto M, et al: FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1987, 40:1249
25. Kino T, Hatanaka H, Miyata S, et al: FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987, 40:1256
26. Bierer BE, Mattila PS, Standaert RF, et al: Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A 1990, 87:9231
27. Marks AR: Cellular functions of immunophilins. Physiol Rev 1996, 76:631
28. Matsuda S, Shibasaki F, Takehana E, et al: Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep 2000, 1:428
29. Handschumacher RE, Harding MW, Rice J, et al: Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 1984, 226:544
30. Harding MW, Handschumacher RE: Cyclophilin, a primary molecular target for cyclosporine. Structural and functional implications. Transplantation 1988, 46:29S
31. Harding MW, Galat A, Uehling DE, et al: A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989, 341:758
32. Fischer G, Bang H: The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl- prolyl cis-trans isomerase. Biochim Biophys Acta 1985, 828:39
33. Takahashi N, Hayano T, Suzuki M: Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989, 337:473
34. Schreiber SL: Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 1992, 70:365
35. Fischer G, Wittmann-Liebold B, Lang E, et al: Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989, 337:476
36. Cardenas ME, Zhu D, Heitman J: Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. Curr Opin Nephrol Hypertens 1995, 4:472
37. Bierer BE, Somers PK, Wandless TJ, et al: Probing immunosuppressant action with a nonnatural immunophilin ligand. Science 1990, 250:556
38. Dumont FJ, Melino MP, Staruch MJ, et al: The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol 1990, 144:1418
39. Liu J, Albers MW, Wandless TJ, et al: Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 1992, 31:3896
40. Liu J, Farmer JD Jr, Lane WS, et al: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807
41. Feng B, Stemmer PM: Interactions of calcineurin A, calcineurin B, and Ca2+. Biochemistry 1999, 38:12481
42. Gupta RC, Khandelwal RL, Sulakhe PV. Interaction amongst calcineurin subunits. Stimulatory and inhibitory effects of subunit B on calmodulin stimulation of subunit A phosphatase activity depend on Mn2+ exposure of the holoenzyme prior to its dissociation by urea. FEBS Lett 1986, 196:39
43. Chaudhuri B, Stephan C: Only in the presence of immunophilins can cyclosporin and FK506 disrupt in vivo binding of calcineurin A to its autoinhibitory domain yet strengthen interaction between calcineurin A and B subunits. Biochem Biophys Res Common 1995, 215:781
44. Husi H, Luyten MA, Zurini MG: Mapping of the immunophilin-immunosuppressant site of interaction on calcineurin. J Biol Chem 1994, 269:14199
45. Clipstone NA, Fiorentino DF, Crabtree GR: Molecular analysis of the interaction of calcineurin with drug- immunophilin complexes. J Biol Chem 1994, 269:26431
46. Kawamura A, Su MS: Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain. J Biol Chem 1995, 270:15463
47. Shaw KT, Ho AM, Raghavan A, et al: Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A 1995, 92:11205
48. Flanagan WM, Corthesy B, Bram RJ, et al: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991, 352:803
49. Ruff VA, Leach KL: Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J Biol Chem 1995, 270:22602
50. Loh C, Carew JA, Kim J, et al: T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol Cell Biol 1996, 16:3945
51. Shibasaki F, Price ER, Milan D, et al: Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996, 382:370
52. Beals CR, Clipstone NA, Ho SN, et al: Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin- sensitive intramolecular interaction. Genes Dev 1997, 11:824
53. Park J, Yaseen NR, Hogan PG, et al: Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J Biol Chem 1995, 270:20653
54. Finn WF: FK506 nephrotoxicity. Ren Fail 1999, 21:319
55. Su Q, Weber L, Le Hir M, et al: Nephrotoxicity of cyclosporin A and FK506: Inhibition of calcineurin phosphatase. Ren Physiol Biochem 1995, 18:128
56. Pascual M, Swinford RD, Ingelfinger JR, et al: Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 1998, 19:514
57. Peters D, Tsuchida M, Manthei ER, et al: Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506. Blood 2000, 95:2733
58. Dumont FJ, Staruch MJ, Fischer P, et al: Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol 1998, 160:2579
59. Shin GT, Khanna A, Ding R, et al: In vivo expression of transforming growth factor-beta1 in humans: Stimulation by cyclosporine. Transplantation 1998, 65:313
60. van der Pouw Kraan TC, Boeije LC, Troon JT, et al: Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J Immunol 1996, 156:1818
61. Prashar Y, Khanna A, Sehajpal P, et al: Stimulation of transforming growth factor-beta 1 transcription by cyclosporine. FEBS Lett 1995, 358:109
62. Genazzani AA, Carafoli E, Guerini D: Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc Natl Acad Sci U S A 1999, 96:5797
63. Rafiq K, Kasran A, Peng X, et al: Cyclosporin A increases IFN-gamma production by T cells when co-stimulated through CD28. Eur J Immunol 1998, 28:1481
64. Mascarell L, Frey JR, Michel F, et al: Increased protein synthesis after T cell activation in presence of cyclosporin A. Transplantation 2000, 70:340
65. Sugimoto T, Stewart S, Guan KL: The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase. J Biol Chem 1997, 272:29415
66. Zwilling S, Dieckmann A, Pfisterer P, et al: Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science 1997, 277:221
67. Granelli-Piperno A, Nolan P, Inaba K, et al: The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med 1990, 172:1869
68. Cameron AM, Steiner JP, Roskams AJ, et al: Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell 1995, 83:463
69. Cho CS, Elkahwaji J, Chang Z, et al: Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways. Cell Signal 2002, 15:85
70. Metcalfe S, Alexander D, Turner J: FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. Cell Immunol 1994, 158:46
71. Richter A, Davies DE, Alexander P: Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. Biochem Pharmacol 1995, 49:367
72. Khanna A, Kapur S, Sharma V, et al: In vivo hyperexpression of transforming growth factor-beta1 in mice: Stimulation by cyclosporine. Transplantation 1997, 63:1037
73. Hojo M, Morimoto T, Maluccio M, et al: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999, 397:530
74. Khanna AK, Cairns VR, Becker CG, et al: Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: Demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine. Transplantation 1999, 67:882
75. Khanna A, Cairns V, Hosenpud JD: Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. Transplantation 1999, 67:614
76. Border WA, Noble NA: TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int 1997, 51:1388
77. Border WA, Noble NA, Ketteler M: TGF-beta: A cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int Suppl 1995, 49:S59